Research

We recently had one of our studies approved for funding by United Therapeutics. The study is titled STAPLES: Subcutaneous Treprostinil Associated Pain: Lidoderm Evaluation Study. By April 2003, we expect to start enrolling patients who are experiencing pain from Remodulin delivery. If you are interested in enrolling, please contact us.

Other research interests include:

• Pulmonary hypertension due to sickle cell disease
• Better methods of prostacyclin delivery
• Better indices of therapeutic monitoring in pulmonary hypertension
• And others.